Skip to main content

Table 4 Clinical pregnancy cycle characteristics

From: Expression of antiapoptosis gene survivin in luteinized ovarian granulosa cells of women undergoing IVF or ICSI and embryo transfer: clinical correlations

Characteristics

Clinical pregnancy

 
 

No

Yes

p value*

 

Median [IQR]

Median [IQR]

 

Age (years)

36.00 (33.00, 37.00)

38.00 (36.00, 44.00)

0.069

FSH (IU/L)

6.3 (5.50, 7.90)

5.5 (4.10, 8.50)

0.634

PRL (ng/mL)

12.10 (7.20, 16.1)

19.20 (11.70, 22.60)

0.054

Total gonadotropin dosage

3,075.00 (2,275.00, 3,675.00)

2,625.00 (2,325.00, 3,175.00)

0.398

Estradiol, 5th day of rFSH administration (pg/mL)

400.00 (252.00, 691.00)

450.00 (309.00, 509.00)

0.572

Estradiol, peak (pg/mL)

2,022.00 (1,561.00, 2,569.00)

2,188.50 (1,254.00, 2,805.00)

0.686

Number of oocytes retrieved

8.00 (6.00, 10.00)

9.00 (6.00, 10.00)

0.765

Mature oocyte ratio (%)

71.00 (60.00, 78.00)

68.50 (67.00, 83.00)

1.000

Survivin/ABL

0.50 (0.20, 3.00)

0.3 (0.20, 1.20)

0.246

  1. *Statistical Test.
  2. Clinical pregnancy in correlation with patients’ cycle characteristics and survivin/ABL genes expression.